Literature DB >> 19203986

Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.

Vrinda Nair1, S Mahadevan.   

Abstract

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorder with a prevalence of 8-12%. Even though psychostimulants remain the treatment of choice, its cost and availability in developing countries limits the usage of the drug. In view of free availability and low cost, a Randomized controlled study was carried out using two second line drugs (clonidine and carbamazepine) in a tertiary care hospital, Pondicherry, South India.
OBJECTIVE: To compare the efficacy of clonidine and carbamazepine in children with ADHD.
METHOD: With approval of ethics committee, a prospective, Double-blind, Randomized controlled study of clonidine and carbamazepine was conducted with 50 children with ADHD (age group 4-12 years), over a period of 2 years (2005-07) in a tertiary care hospital, Pondicherry, South India.
RESULTS: Clonidine was effective in improving the hyperactivity and impulsivity symptoms in children with ADHD as compared to carbamazepine. Statistical significant improvement was not noted with respect to inattention symptoms and other comorbid conditions.
CONCLUSION: Clonidine can be a safer and cheaper alternative in treatment of children with ADHD, with a predominant effect on their hyperactivity and impulsivity symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203986     DOI: 10.1093/tropej/fmn117

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  13 in total

1.  Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.

Authors:  Jamie D Croxtall
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 2.  A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?

Authors:  Paul J Fitzgerald
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

Review 3.  Clonidine extended-release: in attention-deficit hyperactivity disorder.

Authors:  Jamie D Croxtall
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

Review 4.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

5.  Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.

Authors:  Scott H Kollins; Rakesh Jain; Matthew Brams; Scott Segal; Robert L Findling; Sharon B Wigal; Moise Khayrallah
Journal:  Pediatrics       Date:  2011-05-09       Impact factor: 7.124

Review 6.  Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.

Authors:  Shweta Anand; Henry Tong; Frank M C Besag; Esther W Chan; Samuele Cortese; Ian C K Wong
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 7.  What works where? A systematic review of child and adolescent mental health interventions for low and middle income countries.

Authors:  Henrikje Klasen; Anne-Claire Crombag
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-09       Impact factor: 4.328

8.  Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.

Authors:  Diane E May; Christopher J Kratochvil
Journal:  Drugs       Date:  2010       Impact factor: 9.546

9.  Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy.

Authors:  Shivanand Kattimani; S Mahadevan
Journal:  Ann Indian Acad Neurol       Date:  2011-01       Impact factor: 1.383

Review 10.  Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders.

Authors:  Xue Ming; Martha Mulvey; Sharanya Mohanty; Viraj Patel
Journal:  Adolesc Health Med Ther       Date:  2011-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.